PULMICORT RESPULES is approved for
children 12 months to 8 years of age.

PULMICORT RESPULES is a long-term maintenance medicine used to control and prevent asthma symptoms in children ages 12 months to 8 years, PULMICORT RESPULES does not treat the sudden symptoms of an asthma attack.

"Ian would have problems breathing and we wouldn't know what was going on. It turned out that it was asthma"

-kristen B. Mom of child with asthma

If you're asking yourself this question, you are not alone.

PULMICORT RESPULES is a long-term maintenance medicine
used to control and prevent asthma symptoms in children ages
12 months to 8 years, PULMICORT RESPULES does not treat
the sudden symptoms of an asthma attack.

Learn how you can work with your doctor
to help improve your child's asthma symptoms.

PULMICORT RESPULES is a long-term maintenance medicine used to control and prevent asthma symptoms in children ages 12 months to 8 years, PULMICORT RESPULES does not treat the sudden symptoms of an asthma attack.

Safety and
Side Effects

 
PULMICORT RESPULES® (budesonide inhalation suspension) Safety and Side Effects

Using a
Jet Nebulizer

 

Learn how to use a jet nebulizer and get answers to some common questions.

Using a Jet Nebulizer
1171404-3175607 Last updated 9/15

IMPORTANT INFORMATION ABOUT PULMICORT RESPULES

Important Safety Information

PULMICORT RESPULES is not a bronchodilator and should NOT be used to treat an acute asthma attack. If your child is switching to PULMICORT RESPULES from an oral corticosteroid, follow the doctor's instructions to avoid serious health risks when your child stops using oral corticosteroids.

Only use PULMICORT RESPULES with a jet nebulizer machine that is connected to an air compressor. Do not use an ultrasonic nebulizer.

Thrush infection of the mouth and throat may occur with PULMICORT RESPULES.

Avoid exposure of your child to infections such as chicken pox and measles. Tell your doctor immediately if your child is exposed.

Inhaled corticosteroids may cause a reduction in growth rate. The long-term effect on final adult height is unknown.

PULMICORT RESPULES should not be used if your child is allergic to budesonide or any of the ingredients.

Be sure to tell the healthcare provider about all your child's health conditions and all medicines he or she may be taking.

As with other inhaled asthma medications, bronchospasm, with an immediate increase in wheezing, may occur after dosing. If bronchospasm occurs following dosing with PULMICORT RESPULES, it should be treated immediately with a fast-acting inhaled bronchodilator. Treatment with PULMICORT RESPULES should be stopped and your physician consulted.

The most common side effects include respiratory infection, runny nose, coughing, ear infection, viral infection, thrush in the mouth and throat, inflammation of the stomach including vomiting, diarrhea, abdominal pain and loss of appetite, nose bleed, pink eye, and rash.

Approved Use

PULMICORT RESPULES® (budesonide inhalation suspension) is a maintenance medicine used to control and prevent asthma symptoms in children ages 12 months to 8 years.

Please click here for full Prescribing Information for PULMICORT RESPULES.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

This product information is intended for US consumers only.

PULMICORT RESPULES is a registered trademark of the AstraZeneca group of companies.

PARI JET PLUS Nebulizer and PARI MASTER Compressor are registered trademarks of PARI Respiratory Equipment, Inc.

©2016 AstraZeneca. All rights reserved. 1171404-3175607 Last Updated 3/16